Venomous Snakebites Worldwide with a Focus on the Australia-Pacific Region

Current Management and Controversies

Allen Cheng, Bart Currie

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Snakebites are estimated to cause approximately 100,000 deaths each year worldwide and disproportionately affect rural populations in resource-poor settings. Snake venoms may produce local tissue damage and/or distinct clinical syndromes, including neurotoxicity, coagulopathy, hypotension, rhabdomyolysis, and renal failure. Field management is aimed at delaying systemic absorption of toxins, minimizing local damage and infection, and expediting transport to medical facilities. The use of the pressureimmobilization method remains controversial. The use of antivenom, administered in a timely fashion and in adequate doses, is the mainstay of hospital treatment of significant envenomation. The availability, efficacy, and safety of antivenoms vary throughout the world, with a current crisis in antivenom supplies. Copyright � 2004 Sage Publications.
Original languageEnglish
Pages (from-to)259-269
Number of pages11
JournalJournal of Intensive Care Medicine
Volume19
Issue number5
Publication statusPublished - 2004

Fingerprint

Antivenins
Snake Bites
Neurotoxicity Syndromes
Snake Venoms
Rhabdomyolysis
Rural Population
Hypotension
Renal Insufficiency
Safety
Infection

Cite this

@article{f812720a655644359ba673ee2e2a5f2f,
title = "Venomous Snakebites Worldwide with a Focus on the Australia-Pacific Region: Current Management and Controversies",
abstract = "Snakebites are estimated to cause approximately 100,000 deaths each year worldwide and disproportionately affect rural populations in resource-poor settings. Snake venoms may produce local tissue damage and/or distinct clinical syndromes, including neurotoxicity, coagulopathy, hypotension, rhabdomyolysis, and renal failure. Field management is aimed at delaying systemic absorption of toxins, minimizing local damage and infection, and expediting transport to medical facilities. The use of the pressureimmobilization method remains controversial. The use of antivenom, administered in a timely fashion and in adequate doses, is the mainstay of hospital treatment of significant envenomation. The availability, efficacy, and safety of antivenoms vary throughout the world, with a current crisis in antivenom supplies. Copyright � 2004 Sage Publications.",
keywords = "venom antiserum, Australia, first aid, health, human, methodology, Pacific islands, pathophysiology, review, snakebite, Antivenins, First Aid, Humans, Pacific Islands, Snake Bites, World Health",
author = "Allen Cheng and Bart Currie",
year = "2004",
language = "English",
volume = "19",
pages = "259--269",
journal = "Journal of Intensive Care Medicine",
issn = "0885-0666",
publisher = "SAGE Publications Ltd",
number = "5",

}

Venomous Snakebites Worldwide with a Focus on the Australia-Pacific Region : Current Management and Controversies. / Cheng, Allen; Currie, Bart.

In: Journal of Intensive Care Medicine, Vol. 19, No. 5, 2004, p. 259-269.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Venomous Snakebites Worldwide with a Focus on the Australia-Pacific Region

T2 - Current Management and Controversies

AU - Cheng, Allen

AU - Currie, Bart

PY - 2004

Y1 - 2004

N2 - Snakebites are estimated to cause approximately 100,000 deaths each year worldwide and disproportionately affect rural populations in resource-poor settings. Snake venoms may produce local tissue damage and/or distinct clinical syndromes, including neurotoxicity, coagulopathy, hypotension, rhabdomyolysis, and renal failure. Field management is aimed at delaying systemic absorption of toxins, minimizing local damage and infection, and expediting transport to medical facilities. The use of the pressureimmobilization method remains controversial. The use of antivenom, administered in a timely fashion and in adequate doses, is the mainstay of hospital treatment of significant envenomation. The availability, efficacy, and safety of antivenoms vary throughout the world, with a current crisis in antivenom supplies. Copyright � 2004 Sage Publications.

AB - Snakebites are estimated to cause approximately 100,000 deaths each year worldwide and disproportionately affect rural populations in resource-poor settings. Snake venoms may produce local tissue damage and/or distinct clinical syndromes, including neurotoxicity, coagulopathy, hypotension, rhabdomyolysis, and renal failure. Field management is aimed at delaying systemic absorption of toxins, minimizing local damage and infection, and expediting transport to medical facilities. The use of the pressureimmobilization method remains controversial. The use of antivenom, administered in a timely fashion and in adequate doses, is the mainstay of hospital treatment of significant envenomation. The availability, efficacy, and safety of antivenoms vary throughout the world, with a current crisis in antivenom supplies. Copyright � 2004 Sage Publications.

KW - venom antiserum

KW - Australia

KW - first aid

KW - health

KW - human

KW - methodology

KW - Pacific islands

KW - pathophysiology

KW - review

KW - snakebite

KW - Antivenins

KW - First Aid

KW - Humans

KW - Pacific Islands

KW - Snake Bites

KW - World Health

M3 - Article

VL - 19

SP - 259

EP - 269

JO - Journal of Intensive Care Medicine

JF - Journal of Intensive Care Medicine

SN - 0885-0666

IS - 5

ER -